Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Tempest Therapeutics, Inc. Common Stock (TPST)

Pharmaceutical Preparations

https://www.tempesttx.com

Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.

2000 SIERRA POINT PARKWAY, SUITE 400
BRISBANE, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/28/2021

Market Cap

37,559,622

Shares Outstanding

19,250,000

Weighted SO

19,247,495

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

INDP --.--%

RZLT --.--%

CMRA --.--%

FBRX --.--%

SANA --.--%

OLMA --.--%

CGEM --.--%

LIFE --.--%

ZNTL --.--%

Beta

-2.8100

Last Div

0.0000

Range

0.17-9.77

Chg

-0.0600

Avg Vol

2853320

Mkt Cap

37559622

Exch

NASDAQ

Country

US

Phone

415 798 8589

DCF Diff

0.2848

DCF

1.2045

Div Yield

0.0000

P/S

0.0000

EV Multiple

-0.8518

P/FV

1.9832

Div Yield %

0.0000

P/E

-1.0581

PEG

-0.0265

Payout

0.0000

Current Ratio

2.1669

Quick Ratio

2.1669

Cash Ratio

2.1378

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

591.0561

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

0.0162

ROA

-0.7529

ROE

-2.0110

ROCE

-1.1468

NI/EBT

1.0000

EBT/EBIT

1.0027

EBIT/Rev

0.0000

Debt Ratio

0.2749

D/E

0.6843

LT Debt/Cap

0.1060

Total Debt/Cap

0.4063

Int Coverage

0.0000

CF/Debt

-2.1875

Equity Multi

2.4895

Rec Turnover

0.0000

Pay Turnover

0.6175

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-1.1247

FCF/Share

-1.1435

Cash/Share

1.3804

OCF/Sales

0.0000

FCF/OCF

1.0167

CF Coverage

-2.1875

ST Coverage

-2.6459

CapEx Coverage

-59.8066

Div&CapEx Cov

-59.8066

P/BV

1.9832

P/B

1.9832

P/S

0.0000

P/E

-1.0581

P/FCF

-1.4568

P/OCF

-1.3248

P/CF

-1.3248

PEG

-0.0265

P/S

0.0000

EV Multiple

-0.8518

P/FV

1.9832

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Sep 20, 20:30 Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. Jun 18, 22:22 Tempest to Report New Data from Global Randomized Combination Study of Amezalpat (TPST-1120) in First-Line Hepatocellular Carcinoma GlobeNewswire Inc. Jan 05, 16:05 Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) PennyStocks Nov 22, 11:16 Penny Stocks To Buy? 5 To Watch Right Now GlobeNewswire Inc. Nov 08, 17:17 Tempest Reports Third Quarter 2023 Financial Results and Provides Business Update

Revenue Product Segmentation